ASN Podcast

In this episode, Tod and David discuss recent updates from within the Department of Health and Human Services, including changes in the OPTN, the back-and-forth between the FDA and CMS on the accelerated approval of drugs, and more.

In this episode, David speaks with Zach Kribs, ASN Manager of Congressional Affairs, on Kidney Community Advocacy Day, ASN's goals for Hill Day 2023, Congressional priorities in 2023, the debt ceiling, and more.

In this episode, Tod and David discuss ASN's responses to recent regulatory proposals, including technical changes in the Medicare Advantage program, the 2728 form, and the USPSTF.

In this episode, Tod and David discuss President Biden's State of the Union address and its implications for the kidney community through 2024.

In this episode, Tod and David discuss today's political landscape, the debt ceiling, priorities and considerations for the kidney community in 2023, and more.

In this episode, ASN Manager of Congressional Affairs, Zachary Kribs, joins Tod and David in discussing what to expect from Congress going into 2023.

In this episode, Tod and David discuss what to expect from Congress going into 2023, including the debt ceiling, inflation, appropriations funding, and entitlement programs.

Tod Ibrahim and David White interview Zachary Kribs, ASN Manager of Congressional Affairs, on what to expect during the lame-duck session of Congress, agenda items for the newly elected Congress, and funding for kidney health projects in the future.

In this episode, Catherine Godson, PhD, leads a discussion with Orlando M. Gutierrez, MD, and Josh Waitzman, MD, PhD, on day 3 of Kidney Week.

In this episode, ASN Kidney Week Committee Co-Chair Kirk Campbell, MD, FASN, leads a discussion with Precious McCowan, MS, and Amy Mottl, MD, MPH, FASN, about day 2 of Kidney Week.

In this episode, ASN President Susan E. Quaggin, MD, FASN, leads a discussion with S. Ananth Karumanchi, MD, and Rachel Lennon, MBBS, PhD, about day 1 of Kidney Week and returning to an in-person program.

Tod and David interview Melissa West, ASN's Senior Director for Strategic Relations and Patient Engagement, about the ASN Taskforce on the Future of Nephrology.

Tod and David discuss the aftermath of the Supreme Court's decision in Marietta Memorial Hospital Employee Health Benefit Plan v. DaVita, Inc. and ASN's response to the Centers for Medicare and Medicaid Services' proposed rules and the

In this episode, Tod and David discuss the proposed rules for the CMS ESRD Prospective Payment System Quality Incentive Program, ASN's responses to the proposed regulation, other issues ASN is working to address, and much more.

In this episode, Tod Ibrahim and David White discuss the ESRD Benefits Program in 2023, the Inflation Reduction Act of 2022, and the Medicare Secondary Payer Act.

In this episode, Tod Ibrahim interviews Drs. Deidra Crews and Keisha Gibson on the ramifications of removing race from the eGFR equation and the next steps in addressing health disparities.

Tod Ibrahim and David White discuss the Supreme Court's ruling on Marietta Memorial Hospital Employee Health Benefit Plan v. DaVita Inc. and the repercussions for health care providers and insurers.

Tod Ibrahim and David White discuss the labor shortages facing nephrology, as well as the implications of private equity getting more involved in health care.

Tod Ibrahim and David White summarize a recent ACP Council of Specialty Societies meeting, touching on medical misinformation, physician burnout, and other issues.

Tod Ibrahim and David White discuss accreditation and certification in nephrology, including issues like updating the curriculum.

Tod Ibrahim talks to Dr. Serhan Tuğlular, council member of the European Renal Association, about how the war in Ukraine has affected kidney care for people in that country.

Tod Ibrahim and David White discuss the details of the latest congressional spending package.

Tod Ibrahim and David White talk to several ASN employees about new developments in the kidney community.

Tod Ibrahim talks to Rachel Meyer, ASN's outgoing Senior Director of Policy and Government Affairs, about the evolution of kidney health and public policy during her tenure.

Tod Ibrahim and David White discuss four updates about kidney policy…with some good news and bad.